Potential Use of the Cholesterol Transfer Inhibitor U18666A as a Potent Research Tool for the Study of Cholesterol Mechanisms in Neurodegenerative Disorders

S Yasamineh, FJ Mehrabani, E Derafsh… - Molecular …, 2023 - Springer
Cholesterol is an essential component of mammalian cell membranes and a precursor for
crucial signaling molecules. The brain contains the highest level of cholesterol in the body …

[HTML][HTML] Fabry disease: cardiac implications and molecular mechanisms

D Weissman, J Dudek, V Sequeira, C Maack - Current Heart Failure …, 2024 - Springer
Abstract Purpose of Review This review explores the interplay among metabolic dysfunction,
oxidative stress, inflammation, and fibrosis in Fabry disease, focusing on their potential …

[HTML][HTML] Up-regulation of cholesterol synthesis by lysosomal defects requires a functional mitochondrial respiratory chain

F Agostini, L Pereyra, J Dale, KF Yambire… - Journal of Biological …, 2024 - Elsevier
Mitochondria and lysosomes are two organelles that carry out both signaling and metabolic
roles in cells. Recent evidence has shown that mitochondria and lysosomes are dependent …

[HTML][HTML] Differential effects of N-acetylcysteine on retinal degeneration in two mouse models of normal tension glaucoma

H Sano, K Namekata, A Kimura, H Shitara, X Guo… - Cell death & …, 2019 - nature.com
N-acetylcysteine (NAC) is widely used as a mucolytic agent and as an antidote to
paracetamol overdose. NAC serves as a precursor of cysteine and stimulates the synthesis …

Linking mitochondrial dysfunction to neurodegeneration in lysosomal storage diseases

A Saffari, S Kölker, GF Hoffmann… - Journal of Inherited …, 2017 - Springer
Lysosomal storage diseases (LSD) are inborn errors of metabolism resulting in multisystem
disease. Central nervous system involvement, often with progressive neurodegeneration …

[HTML][HTML] Mitochondrial cholesterol in Alzheimer's disease and Niemann–pick type C disease

S Torres, CM García-Ruiz… - Frontiers in …, 2019 - frontiersin.org
Mitochondrial dysfunction has been recognized as a key player in neurodegenerative
diseases, including Alzheimer's disease (AD) and Niemann–Pick type C (NPC) disease …

The Extending Spectrum of NPC1-Related Human Disorders: From Niemann–Pick C1 Disease to Obesity

A Lamri, M Pigeyre, WS Garver, D Meyre - Endocrine reviews, 2018 - academic.oup.com
Abstract The Niemann–Pick type C1 (NPC1) protein regulates the transport of cholesterol
and fatty acids from late endosomes/lysosomes and has a central role in maintaining lipid …

[HTML][HTML] Secondary mitochondrial dysfunction as a cause of neurodegenerative dysfunction in lysosomal storage diseases and an overview of potential therapies

KM Stepien, N Cufflin, A Donald, S Jones… - International Journal of …, 2022 - mdpi.com
Mitochondrial dysfunction has been recognised a major contributory factor to the
pathophysiology of a number of lysosomal storage disorders (LSDs). The cause of …

[HTML][HTML] “Turn on” fluorescence sensor of glutathione based on inner filter effect of co-doped carbon dot/gold nanoparticle composites

TH Le, JH Kim, SJ Park - International Journal of Molecular Sciences, 2021 - mdpi.com
Glutathione (GSH) is a thiol that plays a significant role in nutrient metabolism, antioxidant
defense and the regulation of cellular events. GSH deficiency is related to variety of …

[HTML][HTML] Understanding and treating niemann–pick type c disease: Models matter

V Pallottini, FW Pfrieger - International Journal of Molecular Sciences, 2020 - mdpi.com
Biomedical research aims to understand the molecular mechanisms causing human
diseases and to develop curative therapies. So far, these goals have been achieved for a …